3 Patents
- US125655232026Structure-guided Engineering of Peptide-based NLRP3 Inflammasome Inhibitors for Myelodysplastic Syndromes (MDS)
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - US123196852025Small Molecule Pyrin-domain Targeted NLRP3 Inflammasome Inhibitors
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - 0 cites